BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28970710)

  • 1. Transient Elastography (Fibroscan) in Patients with Non-cirrhotic Portal Fibrosis.
    Sharma P; Agarwal R; Dhawan S; Bansal N; Singla V; Kumar A; Arora A
    J Clin Exp Hepatol; 2017 Sep; 7(3):230-234. PubMed ID: 28970710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension.
    Schwabl P; Bota S; Salzl P; Mandorfer M; Payer BA; Ferlitsch A; Stift J; Wrba F; Trauner M; Peck-Radosavljevic M; Reiberger T
    Liver Int; 2015 Feb; 35(2):381-90. PubMed ID: 24953516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of transient elastography with hepatic venous pressure gradient in patients with cirrhotic portal hypertension: A study of 326 patients from India.
    Kumar A; Khan NM; Anikhindi SA; Sharma P; Bansal N; Singla V; Arora A
    World J Gastroenterol; 2017 Jan; 23(4):687-696. PubMed ID: 28216976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-cirrhotic portal hypertension - diagnosis and management.
    Khanna R; Sarin SK
    J Hepatol; 2014 Feb; 60(2):421-41. PubMed ID: 23978714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and pulmonary hemodynamics in patients with non-cirrhotic portal fibrosis (NCPF) is similar to compensated cirrhosis.
    Sharma P; Kumar A; Mehta V; Sharma BC; Sarin SK
    Hepatol Int; 2007 Mar; 1(1):275-80. PubMed ID: 19669349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-cirrhotic portal fibrosis: current concepts and management.
    Sarin SK; Kapoor D
    J Gastroenterol Hepatol; 2002 May; 17(5):526-34. PubMed ID: 12084024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of endoscopic sclerotherapy on long-term management of oesophageal varices: a comparative study of results in patients with cirrhosis of the liver, non-cirrhotic portal fibrosis (NCPF) and extrahepatic portal venous obstruction (EHO).
    Bhargava DK; Dasarathy S; Sundaram KR; Ahuja RK
    J Gastroenterol Hepatol; 1991; 6(5):471-5. PubMed ID: 1932668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-cirrhotic portal fibrosis.
    Sarin SK
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl 3():S214-23. PubMed ID: 12472939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage.
    Piscaglia F; Salvatore V; Mulazzani L; Cantisani V; Schiavone C
    Ultraschall Med; 2016 Feb; 37(1):1-5. PubMed ID: 26871407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal hepatic encephalopathy in patients with cirrhosis by measuring liver stiffness and hepatic venous pressure gradient.
    Sharma P; Kumar A
    Saudi J Gastroenterol; 2012; 18(5):316-21. PubMed ID: 23006459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-cirrhotic portal hypertension.
    Sarin SK; Khanna R
    Clin Liver Dis; 2014 May; 18(2):451-76. PubMed ID: 24679506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study.
    Augustin S; Millán L; González A; Martell M; Gelabert A; Segarra A; Serres X; Esteban R; Genescà J
    J Hepatol; 2014 Mar; 60(3):561-9. PubMed ID: 24211744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shear-wave elastography: a noninvasive tool for monitoring changing hepatic venous pressure gradients in patients with cirrhosis.
    Choi SY; Jeong WK; Kim Y; Kim J; Kim TY; Sohn JH
    Radiology; 2014 Dec; 273(3):917-26. PubMed ID: 25025464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosis.
    Ryu SR; Yoo JJ; Kang SH; Jeong SW; Kim MY; Cho YK; Chang Y; Kim SG; Jang JY; Kim YS; Baik SK; Kim YJ; Park SY; Baymbajav B
    Clin Mol Hepatol; 2021 Jan; 27(1):197-206. PubMed ID: 33317252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroscan Reliably Rules Out Advanced Liver Fibrosis and Significant Portal Hypertension in Alcoholic Patients.
    Salavrakos M; Piessevaux H; Komuta M; Lanthier N; Stärkel P
    J Clin Gastroenterol; 2019; 53(10):772-778. PubMed ID: 30106835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension.
    Seijo S; Reverter E; Miquel R; Berzigotti A; Abraldes JG; Bosch J; García-Pagán JC
    Dig Liver Dis; 2012 Oct; 44(10):855-60. PubMed ID: 22721839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease.
    Bureau C; Metivier S; Peron JM; Selves J; Robic MA; Gourraud PA; Rouquet O; Dupuis E; Alric L; Vinel JP
    Aliment Pharmacol Ther; 2008 Jun; 27(12):1261-8. PubMed ID: 18397389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-cirrhotic portal hypertension versus idiopathic portal hypertension.
    Okuda K
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl 3():S204-13. PubMed ID: 12472938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of histopathological changes in patients with non-cirrhotic portal fibrosis.
    Chougule A; Rastogi A; Maiwall R; Bihari C; Sood V; Sarin SK
    Hepatol Int; 2018 Mar; 12(2):158-166. PubMed ID: 29651703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of transient elastography (FibroScan®) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients.
    Sánchez-Conde M; Miralles P; Bellón JM; Rincón D; Ramírez M; Gutiérrez I; Ripoll C; López JC; Cosín J; Clemente G; Lo Iacono O; Bañares R; Berenguer J
    J Viral Hepat; 2011 Oct; 18(10):685-91. PubMed ID: 21914085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.